NKY(SZ:300109)2022-04-26 16:00Financial Performance - The company's revenue for Q1 2022 was ¥310,869,875.29, representing a 9.21% increase compared to ¥284,648,871.13 in the same period last year[3] - Net profit attributable to shareholders decreased by 47.78% to ¥32,604,859.37 from ¥62,434,932.12 year-on-year[3] - Basic earnings per share dropped by 47.37% to ¥0.10 from ¥0.19 in the same period last year[3] - Net profit for Q1 2022 was CNY 31,554,115.42, down 48.3% from CNY 61,107,761.66 in Q1 2021[25] - The total comprehensive income attributable to the parent company for Q1 2022 was approximately ¥32.79 million, down from ¥65.66 million in the same period last year[26] Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥174,723,246.02, a significant decline of 2,144.64% compared to ¥8,545,411.85 in the previous year[3] - The net cash flow from operating activities for Q1 2022 was negative at approximately ¥174.72 million, a significant decline from a positive cash flow of ¥8.55 million in Q1 2021[30] - The company's cash and cash equivalents decreased to CNY 805,796,265.09 from CNY 1,162,129,054.04 at the beginning of the year, a decline of 30.7%[20] - The ending balance of cash and cash equivalents as of the end of Q1 2022 was approximately ¥741.03 million, a decrease from ¥183.78 million at the end of Q1 2021[30] - The company reported a total cash outflow from operating activities of approximately ¥534.96 million in Q1 2022, compared to ¥296.73 million in Q1 2021[29] Assets and Liabilities - Total assets decreased by 4.65% to ¥3,804,326,924.57 from ¥3,989,887,609.71 at the end of the previous year[3] - The total liabilities decreased to CNY 494,083,874.33 from CNY 589,763,232.70, a decline of 16.2%[22] - The company's equity attributable to shareholders decreased to CNY 3,323,078,308.77 from CNY 3,411,720,076.39, a decrease of 2.6%[22] Research and Development - The company reported a 49.28% reduction in R&D expenses, totaling ¥10,738,557.48 compared to ¥21,173,320.36 in the previous year[8] - The company reported a significant decrease in research and development expenses to CNY 10,738,557.48 from CNY 21,173,320.36, a drop of 49.3%[25] Shareholder Information - The total number of common shareholders at the end of the reporting period is 18,169[11] - The top shareholder, Wang Donghu, holds 8.92% of shares, totaling 30,663,481 shares, with 22,997,611 shares frozen[11] - The company has repurchased a total of 7,348,298 shares, accounting for 2.14% of the total share capital, with a total transaction amount of 134.46 million RMB[17] Government and Taxation - The company received government subsidies amounting to ¥798,690.83, a decrease of 35.04% from ¥1,229,509.26 in the previous year[8] - The company received tax refunds amounting to approximately ¥12.50 million in Q1 2022, compared to ¥2.53 million in the same period last year[29] - The company received the High-tech Enterprise Certificate, which allows a reduced corporate income tax rate of 15% for three years[16] Corporate Governance - The company has appointed two independent directors to its board, enhancing governance and oversight[16] - The company has not disclosed any related party transactions among the top ten shareholders[12] - The company has not participated in margin trading activities among the top ten shareholders[12] Future Outlook - The company plans to continue its market expansion and product development strategies in the upcoming quarters[16]